Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Review of Covid-19 Vaccines and Major Considerations for Diabetic Patients Publisher Pubmed



Soltani S1, 2 ; Zandi M1, 2 ; Shiri Aghbash P3 ; Rezaei M4 ; Mohammadzadeh N5 ; Afsharifar A6 ; Poortahmasebi V3
Authors

Source: Biotechnology and Applied Biochemistry Published:2022


Abstract

The necessity and impact of SARS-CoV2 on the world's health have led to developing and producing practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, and cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. Including SARS, MERS, influenza, and the SARS-CoV-2 provide a safe immune response. Here, we review the information and studies that have been done to help develop strategies and perspectives for producing a safe and ideal vaccine to prevent COVID-19 in normal people, especially at high-risk groups such as diabetes patients. © 2020 International Union of Biochemistry and Molecular Biology, Inc.
Other Related Docs
8. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
9. Covid-19: Significance of Antibodies, Human Antibodies (2020)
13. Potential Antiviral Immune Response Against Covid-19: Lessons Learned From Sars-Cov, Advances in Experimental Medicine and Biology (2021)
16. Insights Into the Sars-Cov2 Outbreak; the Great Global Challenge: A Mini Review, Journal of Cellular and Molecular Anesthesia (2020)
17. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
20. Design of a Multi-Epitope Vaccine Against Sars-Cov-2 Using Immunoinformatics Approach, International Journal of Biological Macromolecules (2020)